Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XEn Plus (also known as Laboratoire XEN) is a Tunisian pharmaceutical and nutraceutical company founded in 2016 and headquartered in Megrine, Ben Arous. The company specializes in the development, manufacturing, and commercialization of dietary supplements, dermo-cosmetics, and therapeutic health products. Its diverse portfolio includes products for sleep enhancement (Dorzen), women's health and fertility (InoPK, Fertillo), and essential mineral/vitamin supplementation (Kela Fer, Kela Zinc, Kela Mag, Trio B). XEn Plus collaborates with international partners, such as Sederma France, to formulate and clinically validate its dermo-cosmetic and therapeutic offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XEn Plus.